Search Weight Loss Topics:

Page 668«..1020..667668669670..680690..»

Listen: The Empty Promise of Vitamins – The Atlantic

Posted: June 18, 2020 at 4:46 pm

Hamblin: If you can add a multivitamin and not change anything, then go for it. Whatever. I mean, you might waste your money.

Wells: Is there really no science behind a vitamin being good for you?

Hamblin: Not unless you have a deficiency in any of those areas.

Wells: And do people generally have deficiencies? Does our modern diet mean you have some deficiencies?

Hamblin: No, you need so little. And anything that you would be likely to get deficient in, we fortify. Even pastas and cereals, theyre fortified with vitamins in case you do just eat packaged foods all the time and never eat fresh produce.

Wells: Youre telling me that, like, my Cheerios have a multivitamin in them?

Hamblin: Oh, yeah. Theyre loaded with vitamins. The reason theres vitamin D in milk is because we add it to the milk. We found ways to make an ultra-processed diet that would avoid vitamin deficiencies. And thats actually a problem for us.

Wells: So our diet is already basically the equivalent of a multivitamin, where weve just randomly put vitamins in the crap we eat?

Hamblin: Thats what fortification is. Its one of those things that is sort of like oxygen. You are getting enough and getting more is not going to help you. The one outlier in the coronavirus-vitamin discussion is vitamin D. Theres almost nothing in our diet that gets us vitamin D. It shouldnt even be called a vitamin, in my humble opinion.

Wells: What is the definition of a vitamin?

Hamblin: There is no definition. Its derived from this marketing term, vital amines. We thought they all had an amine group on them and turns out they dont.

Wells: Thats what vitamin is?!

Hamblin: Yeah. A great book on this is Vitamania, by Catherine Price. It goes into the whole supplement industry and how these ideas started.

Wells: What are vitamins?

Hamblin: Its a random smattering of compounds. We call them micronutrients, as opposed to, say, macronutrients like fats, carbohydrates, and proteins. Micro- nutrients are these tinier ones, which you need, like, the amount of the head of a pin every month. Most of them occur in food. Vitamin D is one that doesnt. You make it yourself being out in the sun. And you dont need a lot, just a few minutes.

There is not evidence that laying out and tanning is good for you. Thats still a major cause of skin cancer. As long as you have some exposure, even just sitting near a window, that should be fine. But there are some serious researchers who believe that there are people who are in a gray area, who might not be getting enough vitamin D, especially when told to stay home. When youre really limiting outdoor exposure, it could be good to take a supplement.

Wells: So its not that vitamin D somehow fights off the coronavirus. Its that if you dont have enough vitamin Dand there could be a slightly elevated percentage of people who dont have enough vitamin D, because were all staying inside a lotthen your immune system can get all wacky, and therefore you would want to take a supplement. What about vitamin C? At the beginning of this, I was taking a vitamin C supplement every day.

See the article here:
Listen: The Empty Promise of Vitamins - The Atlantic

Celery Juice: Benefits, Cleanse, and Recipe – Healthline

Posted: June 18, 2020 at 4:46 pm

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. Heres our process.

Celery juice is rich in nutrients that may have many health benefits.

However, it has become controversial because some people assert that it can cure conditions like cancer, obesity, thyroid issues, and acne.

As such, you may wonder which claims are dubious and which are backed by science.

This article tells you all you need to know about celery juice, including its nutrients, benefits, and downsides.

Because most of its plant fiber has been removed, celery juice packs more nutrients per serving than celery stalks.

Just 1 cup (240 mL) of celery juice provides (1):

Its also rich in many other nutrients, such as zinc, copper, folate, biotin, other B vitamins, and numerous antioxidants (2).

Celery juice is an excellent source of many nutrients, including calcium, potassium, and vitamins A, C, and K.

Celery juice may provide several benefits when consumed as a part of a healthy diet.

Celery juice consists mostly of water and may help you stay hydrated.

Staying hydrated is vital for your body, but many people dont get enough fluids per day. Proper hydration helps manage blood pressure, body temperature, brain function, nutrient delivery, waste excretion, and kidney health (3).

Celery juice is a healthier option than sugary beverages.

A single cup (240 mL) provides just 5 grams of sugar, which is naturally occurring (1).

Sugar-sweetened beverages like soda, energy drinks, and specialty coffees account for up to 50% of added sugar in the U.S. diet and can add an extra 500 calories per day to your total calorie intake (4, 5, 6).

Therefore, choosing low sugar beverages like celery juice may dramatically cut your overall sugar and calorie intake.

Celery juice is high in various plant compounds called phytonutrients, which may reduce inflammation (7).

These compounds act as antioxidants, which help lower oxidative stress. Oxidative stress occurs when unstable molecules called free radicals accumulate in your body (7, 8, 9).

Antioxidant-rich diets are linked to lower rates of chronic ailments, including heart disease, diabetes, obesity, and certain cancers. They may boost skin health as well (10, 11, 12, 13).

Celery juice packs antioxidants that may help lower inflammation in your body. Moreover, its very hydrating and low in sugar, making it a great alternative to sugary beverages.

Though celery juice cleanses are a popular health trend, you should be skeptical of their claims most of which are overblown and arent based on sound science.

Celery juice has soared in popularity due in part to Anthony William, a self-proclaimed health expert with no formal background in nutrition or medicine.

William and others claim that celery juice is a cure-all that heals chronic illnesses due to its undiscovered cluster salts that kill off harmful bacteria in your gut.

However, no evidence supports the existence of these salts.

Moreover, theres only limited research into celery juices effects on acne, diabetes, liver disease, and weight loss (14, 15).

Finally, celery juice does not detoxify your body. Your body has its own natural detoxification system that includes the liver, kidneys, intestines, and lungs (14, 16, 17, 18).

While some people may experience health benefits when they follow a celery juice cleanse, this is likely due to broader lifestyle changes like limiting processed foods or exercising regularly.

To follow the celery juice diet, youre meant to drink 16 ounces (475 mL) of celery juice each morning on an empty stomach and 2432 ounces (710945 mL) if you have a chronic disease.

You then resume a healthy diet for the rest of the day, though specifics arent mentioned. Many people treat the diet as a 10-day cleanse while others follow it long term.

Yet, cleanses and fad diets tend to promote excessive calorie restriction, which can lead to dangerous weight loss, nutrient deficiencies, and hunger (14, 15, 19).

Research also associates juice cleanses with disordered eating and a negative relationship with food (20).

Many claims behind celery juice, such as the idea that it detoxes your body, arent supported by science. Moreover, juice cleanses run the risk of excessive calorie restriction, nutrient deficiencies, and other dangers.

Though celery juice can be nutritious, it carries a handful of downsides.

A single cup (240 mL) of celery juice contains around 215 mg of sodium (1).

As most healthy individuals should limit their daily sodium intake to no more than 2,300 mg, a glass or two of celery juice can contribute significantly to this total (21).

Moreover, the celery juice diet may raise your sodium intake dangerously because it recommends a large amount of juice each day.

In particular, people on salt-restricted diets may wish to avoid celery juice.

Most celery juice is strained to remove its fiber.

Though straining may result in more nutrients per cup (240 ml), fiber is a healthy nutrient that helps keep you full. Without it, your body digests the juice quickly, which may lead you to feel hungry shortly thereafter (22).

For example, replacing a nutritious, fiber-rich breakfast with celery juice may encourage you to eat more calories later in the day.

Additionally, fiber has many health benefits, such as weight maintenance, gut health, and lower cholesterol and blood sugar levels (23).

If you want to ensure proper fiber intake, whole celery stalks are a better bet.

Celery juices low fiber content may increase your hunger and calorie intake, and its high sodium levels are something to watch out for.

If you want to add celery juice to your diet, its easy to make it at home.

Using a juicer is the easiest way to make celery juice. Simply wash 34 celery stalks and run them through the juicer.

If you dont have a juicer, cut 34 washed celery stalks and blend them until smooth. Place a strainer or mesh cloth over a wide-rimmed jug, pour the liquid into the strainer, and press down to extract all the juice.

For a bit of zest and flavor, try adding green apple, fresh ginger, or lemon juice to your drink.

You can also buy celery juice from your local grocery store, but try to avoid those with added sugar or flavorings.

Shop for celery juice online.

Its best to drink this juice alongside a meal full of fiber, healthy fats, and protein to keep your body full and satisfied.

You can make celery juice at home using a blender or juicer. To boost the flavor and nutrient content, add green apple, ginger, or lemon juice.

Celery juice is low in sugar and packed with potassium and vitamins A, C, and K. This popular drink may reduce inflammation and boost hydration, among other benefits.

However, you shouldnt use celery juice to detox your body, as cleanses put you at risk of dangerous calorie restriction and nutrient deficiencies. Furthermore, claims that this juice heals certain diseases are unfounded and not backed by science.

If youre interested in celery juice, be sure to drink it as part of a healthy diet.

Link:
Celery Juice: Benefits, Cleanse, and Recipe - Healthline

EDITORIAL: Diet session ends with Abe failing to address many policy failures : The Asahi Shimbun – Asahi Shimbun

Posted: June 18, 2020 at 4:46 pm

The ruling camps decision to close the regular Diet session on June 17 as scheduled without extending the term amid continued concerns about the new coronavirus reflects the Abe administrations desire to avoid further opposition attacks on its policy failures.

Prime Minister Shinzo Abe and his top aides were clearly unwilling to continue facing questions at the Diet about their responses to the outbreak and other issues. Abe put a higher priority on rebuilding his troubled leadership than on fulfilling his responsibility to explain his policy decisions and actions to the people.

The government claims that the massive reserve fund included in the second supplementary budget for this fiscal year will allow it to make swift policy responses to any unpredictable problems.

Given the lack of transparency in the governments plan to contract out the administrative work for a program to help cash-strapped businesses survive the current crisis, however, it is obvious that the administrations policy actions need to be monitored and checked regularly by the Diet.

NO PROGRESS TOWARD ADDRESSING SCANDALS

There was no time for the Diet to question the governments decision to halt the plan to introduce a U.S.-made Aegis Ashore missile defense system, announced abruptly near the end of the Diet session. This underscored afresh the Abe administrations inveterate tendency to avoid debate on sensitive policy issues and disregard the importance of the role of the Diet.

Before the nation became preoccupied with responding to the coronavirus outbreak, the focus of the regular Diet session was on a series of scandals that had hit the administration.

They include allegations that Abe abused the annual cherry blossom viewing parties he hosted for his personal gain and a bribery scandal concerning Abes policy initiative to introduce casino-centered integrated resorts into Japan. The casino scandal resulted in the arrest and indictment of Lower House lawmaker Tsukasa Akimoto, who was appointed by Abe as senior vice minister at the Cabinet Office in charge of IR projects, for allegedly receiving bribes from a Chinese company seeking to operate a casino in Japan.

The administration has also been struck by an election law scandal involving a top aide to rookie Upper House member Anri Kawai and her husband, former Justice Minister Katsuyuki Kawai, and allegations concerning a dubious sale of state-owned land to Moritomo Gakuen, a private school operator linked to Abes wife, Akie, which drove a Finance Ministry official into suicide.

Notes and the will left behind by the official were later released.

There has been no notable progress toward clarifying the allegations, raising serious doubt over the credibility of the administration. But the Diet session became dominated by challenges posed by the public health crisis.

While dealing with an outbreak of such an unknown virus inevitably involves a trial-and-error process, many Japanese seem to view the series of policy decisions made by the Abe administration in handling the crisis as a chain of delayed responses to the changing situation.

Many political pundits say the administration was slow to take actions to contain the infection partly because Abe was concerned that strong measures could have serious repercussions on Chinese President Xi Jinpings scheduled--and later canceled--state visit to Japan in the spring.

The administration was also concerned about the negative impacts on the 2020 Tokyo Olympics and Paralympics, which have been postponed to next year, as well as on local economies heavily dependent on foreign tourists visiting Japan.

It is quite doubtful whether the administration has made detailed records about its policy responses to the pandemic that are vital for later reviews and assessments of the actions.

Despite its characterization of the outbreak as a historic emergency situation, the Abe administration has failed to keep formal minutes of the meetings of the expert panel advising the government on its responses to the COVID-19 outbreak.

Records of proceedings at special meetings of the prime minister and key Cabinet members responsible for the governments responses to the crisis, where they effectively make related policy decisions, do not include these top policymakers remarks. These facts speak volumes about the administrations lack of commitment to solid management of official documents and adequate information disclosure.

CHANGE OF MIND FORCED BY PUBLIC PRESSURE

Unlike lockdowns imposed in many other countries, the restrictions on outings and business operations in Japan are based only on requests from the government and lack legal enforceability supported by punishment for violations. Public trust in the administration is crucial for the success of this unique approach, which depends on voluntary efforts by a broad range of individual citizens.

But Abes efforts to communicate his policies to the public have been insufficient, and his habit of reading prepared texts instead of speaking in his own words has not helped get his messages out to the public.

Abes initiatives included distributing face masks to all households amid a serious shortage and sharing a video of himself lounging on a sofa with his dog, along with a message telling people to stay at home, in response to popular musician Gen Hoshino, who uploaded a video of himself singing about dancing indoors and invited people to reciprocate.

Both of Abe's actions,based on advice from a small number of close aides, only impressed upon the public how divorced he is from the peoples feelings.

While the administrations long-criticized evil tendencies hobbled its effective handling of the pandemic, there have been unusual cases of the administration being forced to drop policy initiatives that it previously would have forcibly pushed through.

One is its decision to give up enacting legislation to give the government the discretion to extend the legal retirement ages of top public prosecutors.

The legislative initiative provoked a wave of protests in social media and prompted a group of retired top prosecutors led by former Prosecutor-General Kunihiro Matsuo to submit a position paper expressing opposition to the revision to the Justice Ministry.

The controversial bill to revise the Public Prosecutors Office Law was discarded on June 17 as the Diet session ended. If the administration intends to make sincere responses to the public opinion, it should give up on this dubious initiative altogether.

Another notable change in a policy decision concerns the centerpiece of the governments package of measures to ease the economic impacts of the outbreak.

It retracted the Cabinet decision to provide 300,000 yen ($2,800) to families suffering from falling incomes, which did not go down well with the public, and then, in response to a strong request from Komeito, the junior coalition partner of the ruling Liberal Democratic Party, switched to handing out 100,000 yen in cash to every resident.

The Abe administration has lost much of its once strong political momentum, which was supported by his dominant political power and high approval ratings. But it is too early to predict that his weakened power base will lead him to adopt a humbler approach to governing the nation.

POLICY DECISIONS SHOULD NOT BE BASED ON MISPLACED PRIORITIES

Abe is in his eighth year in office since he returned to power, with a little more than a year left until the end of his term as the LDP president.

After leading the ruling coalition to a major victory in the Upper House election last year, Abe tried to accelerate his long-cherished ambition to amend the Constitution. But no wave of public support for his efforts emerged.

The Commissions on the Constitution of both houses did nothing to promote the cause during the latest Diet session but hold just one session of free discussions.

Abes efforts to move ahead Japans negotiations with Russia over a bilateral peace treaty by leveraging his personal relationship with Russian President Vladimir Putin have produced no progress.

Whether the Tokyo Olympics will be held next year will depend on an end to the pandemic.

Abe should not be criticized for trying to leave some legacies of his long rule. What he should focus on at the moment as this nations leader, however, is the colossal challenge of keeping the virus under control while resuscitating the moribund economy.

The remaining restrictions on cross-prefecture movements and operations of certain types of entertainment facilities, such as bars and clubs that provide companionship, are to be lifted on June 19.

With the threats of a possible second and third wave of infections looming on the horizon, the Abe administration needs to put the top policy priority on efforts to safeguard peoples lives and livelihoods and secure the health of the nations social and economic systems.

The ruling and opposition camps have agreed to hold weekly special committee sessions in both houses even while the Diet as a whole is in recess.

If Abe wants to regain the public's trust, he needs to answer questions at these sessions to clarify all the allegations against his administration.

--The Asahi Shimbun, June 18

Read more:
EDITORIAL: Diet session ends with Abe failing to address many policy failures : The Asahi Shimbun - Asahi Shimbun

Here’s a guide to a healthy diet to prevent greying hair – Indulgexpress

Posted: June 18, 2020 at 4:46 pm

OhGod! My hair has started turning grey suddenly. We all have gone through this one dilemma, wherein we dont want our hair to get grey but at the same time its always been told that grey hair is linked to wisdom. Well, thats a tough decision whether to show your wisdom or your grey hair. But, its a fact of life that as we get older, greying of hair sets in. In fact, one-third of us go grey under the age of 30. The problem of premature greying of hair can be the result of different factors, key ones being genetic predisposition, hormonal rise and fall, addiction to smoke and stress and strain of modern lifestyle. The insufficient pigmentation of the hair follicle and the absence of melanin cause the scalp to have a mix of grey and white hair. Studies have also shown that grey hair is formed when a hair follicle starts building up too much hydrogen peroxide. Your hair follicle creates hydrogen peroxide naturally, but when the balance is disturbed or any malfunctioning happens, thats when we start seeing the occurrence of grey hair. While there is no cure for going grey (except by camouflaging it with hair colour), few tips will teach you how to stop grey hair at an early age to some extent.

Vitamins, minerals and nutritional deficiencies may also be one of the major causes of greying hair. In order for hair to look and grow healthy, and have that shine, hair needs proper amount of nutrients. Without a proper and balanced diet, our hair and skin begin to look haggard and weary. Grey hair and baldness are linked to stress because our response to anxiety is often stress-eating, and we deprive our body of the proper nutrition that it needs. Eating a balanced nutritious meal is necessary in order to maintain hair colour and to retain a healthy hair, besides having sufficient melanin.

Certain foods have been found to help in melanin production and prevent the greying of hair, and these can be incorporated into our diet to maintain the natural colour.

- A diet rich in copper can help your body naturally restore melanin in your hair. Some foods that contain a good amount of copper are almonds and cashews, mushrooms, lentils, potato, green leafy veggies, chickpeas, etc. Whole grains, lean meat and fish generally contain up to 50 percent of the required copper intake from a balanced diet. Tyrosine from food also helps in absorbing a good amount of copper from food, tyrosine can also be found in many natural sources like pumpkin seeds, lima beans and sesame seeds. Another good idea to improve your skins and body health is to eat nuts and legumes, peanuts, prunes and dried beans in your routine.

- Eating iron-rich food can add benefits to a copper-rich diet when attempting to restore melanin in your hair. Dark green vegetables such as spinach, fenugreek and kale or yellow fruits such as bananas and tomatoes, kidney beans, lentils, ragi etc are excellent sources of iron. Low iron levels are associated with early graying.

- Berries like strawberries, raspberries and cranberries, oranges, male, etc have an abundant amount of Vitamin C that promotes growth of healthy hair and also prevents premature greying.

- Dairy products like organic milk, curd and paneer are rich in Vitamin B, Vitamins B-6 and B12 that are vital for the production of red blood cells. This promotes oxygen and nutrients supply to your scalp.

- Refined and processed foods such as white flour, refined sugar and all products made from them, soft drinks, pastries, jams and jellies should be avoided. These unhealthy foods dont provide any nutrition and take away energy and cause wrinkles, unattractive skin, grey hair, and premature old age. Stay away from junk food as much as possible.

- Finally comes massaging your head withcoconut oil. It is one of the healthiest oils for your scalp. Not only does it prevent lice and dandruff, it promotes the regrowth of damaged or greying hair. Application of coconut oil on scalp and also on hair nourishes hair and consequently prevents premature greying of hair, plus it also conditions hair better than any other synthetic or chemical products available in the market. Application of warm coconut oil makes the hair sparkling, soft, and smooth and in the long run it also slows down the growth of grey hair. By massaging this oil into the hair roots and scalp, natural melanin production can be boosted. You can also combine this oil with lemon juice or Indian gooseberry (amla) for an additional melanin boost to your scalp. Curry leaves can also be boiled in coconut oil, this is a popular home remedy and an excellent hair tonic to stimulate hair growth and increase hair pigmentation.

- As I mentioned earlier, grey hair can also be caused by hydrogen peroxide built up. This can be successfully neutralised by the catalase enzyme. And where can we find that stuff? Dont worry, its in our humble onion. The remedy is simple just mix one part onion juice with one part lemon juice. Massage this into your scalp daily, and then wash off. You will definitely get the results.

These treatments are very effective at an early age to prevent greying and to maintain good scalp health, so follow it and get healthy hair. Above all, follow a youthful and positive attitude. The latter is a great buffer against lifes stresses, including stress-related greying of hair.

Chief Nutrition Officer, Luke CoutinhoHolistic HealingSystems. Thewriter is a clinicalnutritionistwith a focus onhealthy lifestylechoices.

Go here to read the rest:
Here's a guide to a healthy diet to prevent greying hair - Indulgexpress

What Are Your Osteoporosis Medication Options? – HealthCentral.com

Posted: June 18, 2020 at 4:46 pm

On this page:BasicsBisphosphonatesRANKL InhibitorsHRTSERMsTSECAnabolic AgentsOther DrugsSupplements

Whether you have risk factors for developing osteoporosis or youve been diagnosed, you may wonder what the best avenues are for strengthening your bones. While theres no cure for this bone-thinning condition, with the right meds, you can see improvement and slash your risk of fractures.

Osteoporosis means porous bones. In short: Its a condition that occurs when you lose more bone mass than your body can make. Think of your bones as a bank account: You spend the first couple of decades of your life socking away bone (money) for retirement. When you reach age 30 or so, youll hit your peak bone massthe highest bone mass youll have in your lifetime. When youre a kid, a calcium-rich diet, exercise, and general good health yield healthy bone development.

If you skimped on any of the above (say, due to a childhood illness), your peak bone mass might be on the low side. Once you reach that retirement age (over 50), youll need to make some withdrawals; this is when you start losing bone mass naturally and bone formation slows.

If you didnt have a great peak bone mass to start with, you could get into trouble, leaving bones thin, brittle, and vulnerable to breaks. Certain risk factorssuch as being a postmenopausal woman or having a family history of osteoporosiscan also mean youll lose bone at a faster-than-normal rate.

The end goal of all osteoporosis treatments is to stabilize your bone densitymeaning, prevent you from losing additional bonerather than achieve a complete cure. These meds are designed to slow your bone loss, and in some cases, help make new bones, so yours are less vulnerable to fracture (breaking).

Thats important because fractures arent just painful they can be debilitating, leading to loss of mobility and independence, financial strain, and even death. The mortality rate a year after a hip fracture is about 22 percent. Yet, osteoporosis causes a staggering number of bone breaks a year: 1.5 million to be exact, according to research in the Journal of the American Medical Association.

To answer that, lets start with what actually constitutes osteoporosis. The condition is often diagnosed when you have a bone density scan, a test that measures your bone mineral density (BMD).

The most common BMD test is a dual-energy X-ray absorptiometry or bone densitometry referred to as a DXA or DEXA scan. It checks the mineral levels in your bones, comparing your level to that of a 30-year-old of the same gender. The idea is to see how far your bone density has deviated since then. Heres how to read your results, known as a T-score:

If youve suffered a fracture, your doctor will likely do a bone density scan to see if osteoporosis is at play. The scan is also routinely given to women starting at age 65 (at risk women can start at 60) and to men starting at 70 years old.

Your doctor will also determine how likely you are to fracture a major bone within the next 10 years via a Fracture Risk Assessment Tool (FRAX). If you have osteopenia and a low risk of fracture, you probably wont be treated with an osteoporosis drug. Instead, the recommendation is to make lifestyle changes to improve, or at least stabilize, your bone density. What kinds of tweaks are we talking about? These may include:

However, if youre diagnosed with osteopenia and have a high risk of fracture, your physician may start you on osteoporosis meds to slow down your bone loss before it becomes osteoporosis. Medications arent always a given though. A person who is diagnosed relatively young with no history of fractures and is otherwise healthy may not need meds just yet.

A few drug classes for osteoporosis that work in different ways to prevent fracture and a treatment plan may include one of the following types of drugs:

This family of meds give your natural bone production a chance to play catch-up by slowing or stopping resorption, when bones break down and release minerals such as calcium into your blood. They home in on and inhibit osteoclasts, the cells that do the breaking down. Antiresorptive drugs include:

Youve probably heard of Fosamax or Boniva (or the Boniva generic ibandronate). Theyre part of this drug class the most commonly prescribed for osteoporosis. Bisphosphonates work by slowing down those osteoclasts, giving your osteoblasts (the bone-building cells) a chance to get ahead. Examples include:

Most drugs come with some risk of side effects, and bisphosphonates are no exception. The most common side effects of bisphosphonates are:

There is a side effect from Fosamax called osteonecrosis of the jaw (loss of blood supply to this bone). Its a risk with all bisphosphonates, but its rare and usually seen in people receiving high doses of the meds during cancer treatments. Another less common side effect is atypical femoral fracture; (yes, an osteoporosis med can actually cause a bone break). Long-term use is linked to breaks in the upper thigh area. Zoledronic acid side effects can also include flu-like symptoms, but theyre temporary.

To reduce the risk of the more serious side effects, current osteoporosis treatment guidelines for bisphosphonates call for reassessing a patients fracture risk after three to five years. If your risk of fracture is low-to-moderate after treatment, you may be able to take a break from the drugs; those who are still high risk can remain on bisphosphonates for up to 10 years.

These injections work by neutralizing RANKL, a protein thats necessary for osteoclasts to do their job breaking down bone. Theyre given via injection every six months, depending on the brand, for up to 10 years. Example include:

RANKL injections can also lead to atypical fractures, and that risk is even greater if you suddenly stop treatment. A study in the journal Osteoporosis International found a five percent increase in multiple vertebral fractures after halting the osteoporosis treatment injection.

HRT cuts down on fragility fractures by 20 to 35 percent, studies have shown, but because of its potential health risks (pulmonary embolism, cardiovascular issues, and breast cancer are just a few), its considered a last resort treatment for osteoporosis alone and is reserved for women who are experiencing both menopause symptoms and osteoporosis. Side effects can include:

HRT is approved for women in the form of daily oral tablets and transdermal patches that are applied daily or weekly.

SERMs arent hormones, so they dont carry the same risks as traditional HRT, but this class of drugs does act similar to estrogen in the body by reducing menopause systems and fortifying your bones and preventing fracture, particularly in the spine.

Its a good option for women who are dealing with both menopause symptoms and osteoporosis, but have a high risk of breast cancer that eliminates HRT as an option. SERMs are taken as a daily tablet. One example is Evista (raloxifene), a daily oral tablet approved for women. Evitas most common side effects are:

This type of drug, like Duavee (conjugated estrogens/bazedoxifene) combines estrogen with a SERM to help with severe menopause symptoms such as hot flashes and boost bone mineral density. Research has shown it can increase both spine and hip density after 12 months. Its a daily tablet thats taken orally. Side effects can include:

Because TSEC contains estrogen, it carries some of the risks of HRT.

These are your bone builders. This osteoporosis drug class is designed to stimulate osteoblasts, the cells that beef up bone formation. Theyre typically reserved for more severe cases of osteoporosis where the risk of fracture is very high. Anabolics include:

The most common side effects of these osteoporosis treatment injections are:

The newest bone maker on the block, romosozumab-aqq, is an anti-sclerosin monoclonal antibody approved for postmenopausal women with high risk of fracture. It comes with a risk of cardiovascular issues, so if youve had a heart attack or a stroke within the past year, this is not an ideal drug. Teriparatide and abaloparatide are synthetic versions of parathyroid hormone, which regulates calcium, essential for strong bones.

While worries about side effects may give you pause about filling your prescription for osteoporosis meds, its important to remember this: The benefits of preventing a fracture (and all that comes with it) win out over the risks of taking these meds, according to guidelines from the Endocrine Society published in The Journal of Endocrinology & Metabolism.

Its not widely done, but theres evidence that pairing an antiresorptive with an anabolic agent may yield better results than giving one drug alone. One study in the Journal of Bone and Mineral Research showed combining the bisphosphonate zoledronic acid with the anabolic teriparatide boosted bone mineral density in the spine and hip more than either drug alone.

In an analysis of seven studies, research in the BMJ Open found that a combo of the two drug classes greatly improved bone mineral density of the hip and spine more quickly than an anabolic agent alone. Some doctors will also give an anabolic first (in severe cases) and prescribe a bisphosphonate to maintain your newly formed bone mass.

While bisphosphonates and anabolic agents are the most common osteoporosis medications, some drugs that are used to treat other conditions that can also have a positive effect on bone density.

Youve probably heard steroids are bad for bones. Its true; long-term use of corticosteroids (synthetic drugs that are similar to cortisol, a hormone your body produces) deteriorates bone mineral density, causing osteoporosis. But low doses of anabolic steroids (synthetic versions of the male hormone androgen) may have the opposite effect, stimulating bone growth and reducing osteoporosis pain from fractures, according to research in Clinical Calcium. However, theres limited data to know the long-term side effects of anabolic steroids.

This used to be a malaria medication. How can that possibly help your bones? Hydroxychloroquine is antirheumatic, meaning its used to treat rheumatoid arthritis (RA), lupus, Sjgen syndrome, etc. Researchers discovered those treated with Plaquenil had higher bone mineral density than those who werent. Its not FDA approved for osteoporosis and comes with a rare, but serious risk of eye damage in high doses. More common side effects include:

This is another type of bisphosphonate given via IV infusion that slows down bone loss, but its primarily used to treat bone damage from Pagets Disease (a chronic disease that causes deterioration of bone tissue) and certain types of cancer, as well as hypercalcemia (high levels of calcium in blood caused by calcium). Its an option for osteoporosis patients, but zoledronic acid has proved better for fracture prevention.

Right now, there are no natural supplements that experts recommend in lieu of FDA-approved osteoporosis drugs. If youve been searching the internet for that, youve probably come across info on strontium, a trace element, for osteoporosis.

There is some scientific basis on this one. A study found that postmenopausal women who took two grams of strontium ranelate every day for three years suffered 37 percent fewer spinal fractures compared to women taking a daily placebo pill.

Theres also a strontium ranelate-based drug (Protelos) approved in Europe, but not here in the US. (Its associated with some serious side effects such as pulmonary embolism and heart attacks.) So, should you take an over-the-counter version of the mineral, such as strontium citrate or strontium chloride, to strengthen your bones? Not so fast. These are not the same as strontium ranelate, and theres no evidence they work.

What about OTC estrogen pills? Phytoestrogens, plant-based versions of the hormone such as soy and flaxseed, have some limited data behind them to show that they may help slow bone loss. But physicians say not enough to replace your prescribed medication. Phytoestrogens in your diet may be better at preventing low bone density than treating osteoporosis.

No one drug stands out as the safest; all medications have side effects. Youll have to weigh the pros and cons of each with your physician to find the right fit for you. Typically, bisphosphonates are well tolerated and have been shown to be safe to take for up to 10 years, which is why theyre the first line of treatment for osteoporosis.

Theres no cure for osteoporosis, but you can strengthen bones and reduce the risk of fracture by taking medications and making lifestyle changes. These include: boosting your calcium and vitamin D intake, doing weight-bearing exercises at least three days a week, drinking less alcohol (no more than one to two drinks a day), and if youre a smoker, quitting.

No, osteoporosis drugs are not a lifelong commitment. You can take bisphosphonates for up to 10 years, but the latest osteoporosis guidelines suggest reassessing a patients bone density between three and five years, and, if possible, taking a break from the drugs. Bisphosphonates linger in your bones after you stop taking them, so you have some built-in protection. RANKL agents such as Prolia can be used up to 10 years, while anabolic agents can only be given for up to two years.

The risk of suffering a fracture is far greater than incurring some of the most serious side effects of medication. One in two women over age 50 will fracture a bone and fractures can be extremely painful and debilitating. Need more convincing? Consider this stat from a New York Times article: For every 100,000 women taking bisphosphonates, fewer than three will have osteonecrosis of the jaw, and only one will suffer an atypical femoral fracture. But 2,000 will have avoided an osteoporotic fracture.

Visit link:
What Are Your Osteoporosis Medication Options? - HealthCentral.com

Kawais arrested over suspected vote-buying in 2019 Diet election : The Asahi Shimbun – Asahi Shimbun

Posted: June 18, 2020 at 4:46 pm

A former justice minister and his lawmaker wife were arrested on June 18 on suspicion of handing out money to buy votes in her successful campaign in the 2019 Upper House election.

Prosecutors on June 18 asked Lower House member Katsuyuki Kawai, 57, and his wife, Anri, 46, an Upper House member, to appear for questioning, sources said. The arrests were made based on a warrant requested by the Tokyo District Public Prosecutors Office for the couple on the same day.

Lawmakers cannot be arrested when the Diet is in session. But the current session ended on June 17.

Investigators have been looking into allegations that the couple distributed about 26 million yen ($243,000) to 100 prefectural and city assembly members and others in Hiroshima Prefecture in a bid to secure votes for Anri, who won her first seat in the Diet in the 2019 election.

Both lawmakers have denied any wrongdoing during questioning by prosecutors on a voluntary basis.

The ruling Liberal Democratic Party on June 17 formally approved the Kawais request to leave the party.

The Kawais are close associates of Prime Minister Shinzo Abe and Chief Cabinet Secretary Yoshihide Suga.

Katsuyuki was appointed as justice minister by Abe during a September 2019 Cabinet reshuffle, but he stepped down after about a month because of weekly magazine reports alleging possible campaign violations by Anris staff.

A policy aide to Anri was found guilty on June 16 of violating the Public Offices Election Law by paying more than double the legal amount to staff who rode in campaign cars and shouted out the candidates name.

During the investigation into the aide, prosecutors found a list of names of local assembly members who were given money by the Kawais to help round up votes for Anri in the election.

Prosecutors have questioned those local assembly members, and many said they clearly knew what the money they received was intended for, sources said.

Investigative sources said that after Anri announced in March 2019 that she planned to run in the summer Upper House election, Katsuyuki provided cash payments to about 95 Hiroshima assembly members and others. The total amount given was about 24 million yen.

Anri herself is also suspected of giving five individuals a total of 1.5 million yen.

Investigators believe that Katsuyuki played a central role in the distribution of the cash because he was in charge of Anris campaign.

Katsuyuki has won seven terms in the Lower House from a Hiroshima Prefecture district.

A Hiroshima prefectural assembly election was held in April 2019, and some of those who received cash from Katsuyuki were told the money was in relation to their own elections.

But all those who received the money were also asked to support Anri in the Upper House election.

Prosecutors reached the conclusion that the distribution of money to a wide range of individuals and the large amount involved was an organized attempt to buy votes for Anri, a violation of the Public Offices Election Law.

More here:
Kawais arrested over suspected vote-buying in 2019 Diet election : The Asahi Shimbun - Asahi Shimbun

Testosterone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2026 – Cole of Duty

Posted: June 18, 2020 at 4:45 pm

Testosterone Replacement Therapy Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026) the new research report adds in kandjmarketresearch.com research reports database. This Research Report spread across 47 Pages, with summarizing Top companies and supports with tables and figures.

A fresh specialized intelligence report published by KandJ Market Research with the title Testosterone Replacement Therapy Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026) has the ability to help the decision-makers in the most important market in the world that has played a significantly important role in making a progressive impact on the global economy.

Market Overview:-

The global Testosterone Replacement Therapy market has been comprehensively analyzed in the report and presents the scope of growth of the market that can be expected during both the base period from the year 2016 to the year 2026 and for the forecast period from the year 2016 to the year 2026. The market overview of the Testosterone Replacement Therapy industry is also included in the report. The trends that are expected to be successful during the forecast period due to the growth of the Testosterone Replacement Therapy market are identified and are presented in detail. The Testosterone Replacement Therapy market report is a valuable source of guidance.

Market Dynamics:-

The global Testosterone Replacement Therapy market growth can be either boosted or declined based on different factors. These factors are analyzed in detail to predict the effect that they can have on the global Testosterone Replacement Therapy market and are categorized as such. These factors also play a major role in deciding the direction that the Testosterone Replacement Therapy market can take. The market growth rate from the year 2016 to the year 2026 has been presented based on the volume of products sold and the value of each unit produced. The data has been forecast from the year 2016 to the year 2026.

The Final Report Will Include the Impact of COVID 19 Analysis in This Testosterone Replacement Therapy Industry.

Get the free Copy of Sample Research Report with Covid-19 Updates @: https://www.kandjmarketresearch.com/sample-request/318327

Segmental Analysis:-

The global Testosterone Replacement Therapy market is divided into different market segments according to different parameters. This smaller segmentation enables greater control and accuracy over the data collected. The report segments that market into smaller regions based on locations around the world. These different regions include Asia-pacific, North America, South America, the Middle East, Africa, and Europe. This segmentation also presents the market share occupied by each of these regions and categorizes them based on the ones that have the largest global market share. The scope of growth of these different regions is also presented in the report for the forecast period from the year 2016 to the year 2026.

Market Analysis by Key Players:

Market Analysis by Type:-

Market Analysis by Applications:-

Research Methodology:-

The data used to compile the Testosterone Replacement Therapy market report has been collected from different primary and secondary sources. This data has to then be analyzed to verify the accuracy while also being error-free. The data is analyzed according to different parameters, one of which is the SWOT analysis. The data is analyzed to identify the strengths and weaknesses of different companies along with the opportunities that can be exploited and the threats that they face from different directions and opponents.

The Final Report Will Include the Impact of COVID 19 Analysis in This Testosterone Replacement Therapy Industry.

Ask for Discount @ https://www.kandjmarketresearch.com/discount/318327

Key Players:

The global Testosterone Replacement Therapy market report identifies different companies that occupy a large market share in the Testosterone Replacement Therapy market. These companies are then subjected to a comprehensive analysis to identify different parameters that have contributed to the growth of the market. The popular trends that these companies use to increase the market share that they occupy are also identified. The different advancements in manufacturing technology that has enabled them to gain an edge over other competitors are also listed. The data related to each of the companies has been presented from the year 2016 to the year 2026 and is predicted for the forecast period from the year 2016 to the year 2026.

Market Analysis by Regions:

The Final Report Will Include the Impact of COVID 19 Analysis in This Testosterone Replacement Therapy Industry.

Enquiry about COVID-19 updates for the Testosterone Replacement Therapy Market Report @ https://www.kandjmarketresearch.com/enquiry/318327

About Us:-

Kandjmarketresearch.com is part of the KnowledgeNJournals Research Firm which provides premium progressive market research reports, statistical surveying, analysis & forecast data for industries and governments from hundreds of publishers around the world. We have almost all top publishers reports in our collection to provide you with instant online access to the worlds most complete and fresh database on a Daily Basis. We are at KandJ Market Research are inspired to help our clients grow by providing appropriate business insight with our huge market intelligence source.

If you have any special requirements for the report, please let us know and we will offer you a customized report on separate regional or country-level reports.

Contact us:-

KandJ Market Research

(Part of KnowledgeNJournals Research)

E-mail: [emailprotected]

Website: https://www.kandjmarketresearch.com

(USA): +1 661 636 6162 | (IND): +91 932 580 2062

Follow this link:
Testosterone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2026 - Cole of Duty

Global Testosterone Replacement Therapy Market Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics & Forecast to 2026 -…

Posted: June 18, 2020 at 4:45 pm

Testosterone Replacement Therapy Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)

In 2019, the global Testosterone Replacement Therapy Market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.

Testosterone Replacement Therapy Market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Testosterone Replacement Therapy Market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.The Report scope furnishes with vital statistics about the current market status and manufacturers. It analyzes the in-depth business by considering different aspects, direction for companies, and strategy in the industry.

After analyzing the report and all the aspects of the new investment projects, it is assessed the overall research and closure offered. The analysis of each segment in-detailed with various point views; that include the availability of data, facts, and figures, past performance, trends, and way of approaching in the market. The Testosterone Replacement Therapy Market report also covers the in-depth analysis of the market dynamics, price, and forecast parameters which also include the demand, profit margin, supply and cost for the industry.

The report additionally provides a pest analysis of all five along with the SWOT analysis for all companies profiled in the report. The report also consists of various company profiles and their key players; it also includes the competitive scenario, opportunities, and market of geographic regions. The regional outlook on the Testosterone Replacement Therapy Market covers areas such as Europe, Asia, China, India, North America, and the rest of the globe.

In-depth analysis of expansion and growth strategies obtained by Key players and their effect on competition market growth. The research report also provides precise information on your competitors and their planning. All of the above will help you to make a clear plan for top-line growth.

Get sample copy of thisreport @ https://www.lexisbusinessinsights.com/request-sample-136812

Top key players @ Endo International, AbbVie, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, and Acerus Pharmaceuticals

The main goal for the dissemination of this information is to give a descriptive analysis of how the trends could potentially affect the upcoming future of Testosterone Replacement Therapy Market during the forecast period. This markets competitive manufactures and the upcoming manufactures are studied with their detailed research. Revenue, production, price, market share of these players is mentioned with precise information.

Global Testosterone Replacement Therapy Market: Regional Segment Analysis

This report provides pinpoint analysis for changing competitive dynamics. It offers a forward-looking perspective on different factors driving or limiting market growth. It provides a five-year forecast assessed on the basis of how they Testosterone Replacement Therapy Market is predicted to grow. It helps in understanding the key product segments and their future and helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments.

Key questions answered in the report include:

What will the market size and the growth rate be in 2026?

What are the key factors driving the Global Testosterone Replacement Therapy Market?

What are the key market trends impacting the growth of the Global Testosterone Replacement Therapy Market?

What are the challenges to market growth?

Who are the key vendors in the Global Testosterone Replacement Therapy Market?

What are the market opportunities and threats faced by the vendors in the Global Testosterone Replacement Therapy Market?

Trending factors influencing the market shares of the Americas, APAC, Europe, and MEA.

The report includes six parts, dealing with:

1.) Basic information;

2.) The Asia Testosterone Replacement Therapy Market;

3.) The North American Testosterone Replacement Therapy Market;

4.) The European Testosterone Replacement Therapy Market;

5.) Market entry and investment feasibility;

6.) The report conclusion.

All the research report is made by using two techniques that are Primary and secondary research. There are various dynamic features of the business, like client need and feedback from the customers. Before (company name) curate any report, it has studied in-depth from all dynamic aspects such as industrial structure, application, classification, and definition.

The report focuses on some very essential points and gives a piece of full information about Revenue, production, price, and market share.

Testosterone Replacement Therapy Market report will enlist all sections and research for each and every point without showing any indeterminate of the company.

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

TABLE OF CONTENT:

1 Report Overview

2 Global Growth Trends

3 Market Share by Key Players

4 Breakdown Data by Type and Application

5 United States

6 Europe

7 China

8 Japan

9 Southeast Asia

10 India

11 Central & South America

12 International Players Profiles

13 Market Forecast 2019-2025

14 Analysts Viewpoints/Conclusions

15 Appendix

Get Complete Brochure @ https://www.lexisbusinessinsights.com/request-sample-136812

About Us:

Statistical surveying reports is a solitary goal for all the business, organization and nation reports. We highlight huge archive of most recent industry reports, driving and specialty organization profiles, and market measurements discharged by rumored private distributors and open associations. Statistical surveying Store is the far reaching gathering of market knowledge items and administrations accessible on air. We have statistical surveying reports from number of driving distributors and update our gathering day by day to furnish our customers with the moment online access to our database. With access to this database, our customers will have the option to profit by master bits of knowledge on worldwide businesses, items, and market patterns

Contact Us:

Lexis Business Insights

Aaryan

(Business Development Manager)

US: +1 210 907 4145

APAC: +91 9867799788

6851 N Loop

1604 W San Antonio,

TX 78249

[emailprotected]

http://www.lexisbusinessinsights.com

More here:
Global Testosterone Replacement Therapy Market Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics & Forecast to 2026 -...

How to launch a drug in a pandemic? Here’s how 4 drugmakers are using digital tools and fast footwork to do just that – FiercePharma

Posted: June 18, 2020 at 4:45 pm

Launching a new drug is an arduous task even in the best of times. Drugmakers build their commercial teams from scratch, spending months of effort and huge sums of money to ensure their med reaches as many physicians, patients and payers as possible.

Add a global pandemic to that challenging situation, and companies are faced with one of two options: Adapt or fail.

In the early months of COVID-19, drugmakers Esperion, Horizon, Eisai and Clarus, among others, faced thatunexpected hurdle to bringing their drugs to market after years of planning and millions of dollars invested.

Produce Novel Biologics with High Purity, Quality and Yield

In this Fierce Biotech webinar we will examine a number of the benefits of Lonzas , XS Pichia 2.0 including : speed, simple fermentation regimes, robust and scalable processes that can be tuned according to the specific objectives of a program, helping to advance new drug candidates through the development pipeline.

For two, Esperion and Horizon, the pandemic was the backdropand often thedriverfor unexpected success for their novel therapies.In the case of Eisai and Clarus, the pandemic hit like a hammer, leaving both drugmakers scrambling for answers to the new challenge.

These talesof hardship, adaptation and sometimessuccess underscore the pharmaceutical industry's needtoquickly pivot to new ways of communicating during extraordinary circumstances. They also may reveal a new path forward for drugmakers in the uncertain future of global pandemics and, potentially, rolling waves of lockdowns.

Here are their stories.

After nabbing back-to-back FDA approvals for their lipid-lowering game-changers Nexletol and Nexlizet in February, Michigan-based drugmaker Esperion planned an aggressivelaunchto takethe fight right to its pricey PCSK9 class rivals.

Esperion's plan was simple: The drugmaker wouldlaunch Nexletol (bempedoic acid)on March 30 to set the stage for combo therapy Nexlizet (bempedoic acid and ezetimibe, also known as Zetia) to hit the market in July. The company would rely on its 300-strong sales team to reach as many physicians as possible and greasethe wheels for the more effective combo's launch.

Then, COVID-19 struck with only weeks to go before Nexletol took the stage. Facing a full-scale commercial pivot to digital, the only option off the table was delaying the drug'sMarch 30 launch date, CEO Tim Mayleben said.

"There was never a question about whether we were going to launch at that time," Mayleben said."The question internally was 'how do we adapt?'"

RELATED:Esperion scores FDA nod for cholesterol-buster Nexletol

Luckily, Esperion had adopteddigital outreach tactics before the pandemic. The companytasked its field managers with migrating the company'spromotional materials online and leaning into virtual meeting platforms like Zoom and Veeva Engage to replace face-to-face interactions with physicians.

That shift didn't happen overnight, Mayleben said. In fact, it took nearlyamonth post-launch to roll out all the digital tools needed to reach out to physicians effectively. That meant painstakingly building an outreach effort:The company went from a few hundred live engagements each week with physicians early on to a few thousand now, Mayleben said.

But one portion of that arduous effort came with an unexpected result. Esperion launched a virtual speaker series in the last week of April that gave doctors an opportunity to hear more about Nexlizet's pending launch. Not expecting a huge turnout, Esperion was shocked to see enormous attendance numbers for those sessionsfive times the number other drugmakers were getting for similar events, Mayleben saidunderscoring an immense interest in Nexlizet's clinical efficacy.

"We have been absolutely stunned at how successful that has been," Mayleben said.

RELATED:Esperion notches 2nd FDA approval with cholesterol-lowering combo Nexlizet

With doctor feedback pouring in from the series, Esperion accelerated its launch plans for Nexlizet, taking the drug to market in early Junea month ahead of schedule. The decision wasn't an easy one, but after Esperion confirmed doctors' interest and the ability of its supply chain to keep pace, the drugmaker ultimately decided Nexlizet was "the right drug at the right time for physicians and patients."

With lockdowns easing across the board, Esperion's sales team is beginning to return to normalor as close to normal as possiblebut the company's pivot to digital outreach likely won't be going anywhere, Mayleben said.

Having a "nimble" corps of territory managers who are well-versedin virtual outreach tools and equipped with digital promotional materials will remain a high priority in a blended commercial future, Mayleben argued.

"This is our make-or-break moment so we have to be inventive, and that inventiveness makes us more patient-focused," Mayleben said.

Horizon Therapeutics, once a company known for the unsavory practiceofbuying older meds and dramatically raising their prices to turn a profit, has trumpeted aplan in recent years to pin its future on a small stable of successful rare disease drugs.

One of the centerpieces of that plan is Tepezza, a bulging eye drug with blockbuster aspirations approved by the FDA in January.

Tepezza launched immediately after that approval, scoringa six-week head start on the pandemic before its commercial team of 100 was sidelined. For CEO Tim Walbert, that meant making an immediate shift to virtual outreach and helping existing patients find access to clinical sites to receive their Tepezza infusions, even as cities and states were locking down.

"Everything you do is fundamentally changed," Walbert said."The question you face is'have you built the right relationships?'If you haven't, having thatdialogue about your drug's benefits [to] patientsyoure going to be chasing without a lot of success."

RELATED:Horizon notches blockbuster FDA approval for rare eye disease med Tepezza

Despite facing a huge hurdle that early into Tepezza's launch, Walbert acknowledged that just six weeks on the market up front helped in getting initial patients on the drug. Unexpected, however, was how popular Tepezza would be so early into its launch.

Once projecting between $30 million and $40 million in Tepezza sales in 2020, Horizon has now upped its forecast to around $200 million in sales in the first year alone. Even that eye-popping increase is only a fraction of what Horizon believes it could have achieved if COVID-19 hadn't happened.

"We were still able to drive an amazing launchwithout COVID-19, we may have been able to do $500 million in first-year sales," Walbert said.

Having digitalpromotional materials ready to go beforethe pandemic gave Horizon reps the ability to quickly pivot to virtual outreach, but existing relationships with doctors and enthusiasm for the drug's results also paved the way for a successful first six months, Walbert said.

Now, with itsreps beginning to venture back out in the field, Horizon is leaning on those same physician relationships to chart the best path forward.

"Were having to redefine and work with each individual physician and ask, 'what is the best way to communicate?' Walbert said. "Were going and having our reps build a plan for each of our physicians to figure out how we can best serve them."

Eisai had its work cut out for it in marketing its recently approvedinsomnia med Dayvigo, a DEA-scheduled drug launching in a market full of generic competitors.

Dayvigo notched its FDA approval in December but was forced to hold back its launch untilDEA scheduling came through inearlyAprilright in the heart of the COVID-19 pandemic. Unlike other drugmakers that stuck to their launch dates, Eisai decided to postpone the rolloutuntil June 1.

That drastic decision effectively sidelined Eisai's 250-strong commercial team and put the drugmaker nearly two months behind schedule on its physician and consumer outreach, and education campaigns. According to Ivan Cheung, CEO and president of Eisai's global neurology business, the decision was all about "sensitivity" tophysicians'role in fighting COVID-19.

"From our commercial launch preparation, weve been ready for a late March launch for a long, long time," Cheung said. "Its nothing to do with readiness;its really about sensitivityduring the COVID-19 pandemic. We have to bea responsible corporate citizen."

RELATED:Eisai preps for launch with insomnia med Dayvigo after buying out Purdue

However, Eisai said it began to hear from physicians who felt the pandemic madeadequate sleep even more important as lockdowns added pressure to patients' daily schedules.

Reason enough, Eisai thought, to move ahead with the Dayvigo launch. Now,it's working with physicians to establish communication moving forwardand doctors were fine with the high-tech approach.

"What we found is that, given the impact on sleep health, theres a lot of enthusiasm," said Tushar Patel, Eisai's executive director and global lead of sleep-wake disorders in the neurology business group. "The majority of physicians weve spoken to are not only interested in learning about the new medicine, but theyre very open to receiving information digitally."

Eisai has also leaned into its digital outreach to consumers for Dayvigo, hoping to establish a place in an insomnia market jam-packed with generic competitors andMerck & Co.'sBelsomra brand, which hit the scene in 2014.

That outreach plan includes Eisai's "Dayvigo Together" online campaign to connect patients with live nurse educators to help them understand their insomnia symptoms and assess whether Dayvigo could be an effective treatment for them.

Being a huge, global drugmaker comes with some obvious benefits during a pandemic, including the sheer resources to weather the storm. But size isn't everything in times of crisis, a lesson that Clarus Therapeutics learned well in the early months of COVID-19.

Clarus, the maker of oral testosterone replacement tabletJatenzo, had a long road to market: The drug'sFDA approval in April 2019 capped off an arduous, years-long clinical development program, CEO Bob Dudley, Ph.D.,said. And then it had to gear up for launch.

With those past challenges in mind, Jatenzo's February rollout plans represented a big milestone not only for Clarus, but also forDudley, who developed AndroGel's topical formula as CEO at Unimedand is now a big believerin Jatenzo's place in the testosterone replacement field.But just as the launchgotunderway, COVID-19 struckhard.

"[Launching a new drug] isa challenging task, and it turned out to be a lot more challenging than I thought," Dudley said.

RELATED:As COVID-19 social media fatigue sets in, pharma begins to restart other health conversations

Clarus' commercial team of 55 was immediately tasked with unlearning their training in face-to-face physician meetings and pivoting to virtual. For any company, that's a tall task, butClarusmade that shift with remarkable speed, Dudley said.

In the space of a single weekend, Clarus' team came up with a game plan to amp up its digital outreach and get back in front of physicianshungry for new options in testosterone replacement therapies.

"We had all of these well-trained, motivated people with a great message to deliver tohealthcareprofessionals," Dudley said. "It necessitated pivoting on a dime and figuringout how we were going to maintain some semblance of a normal launch."

Speaking to doctors virtually wasn't as easy as showing up at their offices,Dudley said, and often requirednot only educating Clarus' team to use virtual meeting technology but also doctors themselves.

"In some cases, they didnt know how to do it," Dudley said of physicians using meeting technology."We found ourselves not only communicating the message of Jatenzo, but we also had to become experts in that side of it as well.

"The flip side of that was physicians, when they embraced the technology, then we found that they were keenly interested in learning about something new."

Now, after the storm of those early months, Clarus is making the shift back to face-to-face conversations, and Dudley said his team has moved with the same sense of purpose and "nimbleness" that allowed it to succeed during the lockdowns.

What will happen in an uncertain future is still unknown, but Dudley said the lessons learned during the lockdown helped his team preparefor a "blended" commercial future.

"In this environment, you have to be nimble," he said."This is why I think weve been able to maintain forward momentum when it could have justcrashed and burned."

Read more:
How to launch a drug in a pandemic? Here's how 4 drugmakers are using digital tools and fast footwork to do just that - FiercePharma

Impact of COVID-19 on Testosterone Replacement Therapy Market 2020 Key Players, Opportunities, Challenges, Trend and Forecast by 2027 | Endo…

Posted: June 18, 2020 at 4:45 pm

Notice:This Content doesnt contains all the Information of the Report please fill the form (via link) and get all interesting information just one click in PDF with latest update with chart and Table of Content

The report offers a systematic presentation of the existing trends, growth opportunities, market dynamics that are expected to shape the growth of the Testosterone Replacement Therapy market. The various research methods and tools were involved in the market analysis, to uncover crucial information about the market such as current & future trends, opportunities, business strategies and more, which in turn will aid the business decision-makers to make the right decision in future.

This Report Covers Leading Companies Associated in Worldwide Testosterone Replacement Therapy Market: AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

We Do Offer Sample of this report. Kindly go through the follow information in order to access the report.

Note- This report sample includes:

Brief Introduction to the research report.

Table of Contents (Scope covered as a part of the study)

Top players in the market

Research framework (Structure Of The Report)

Research methodology adopted by Coherent Market Insights

Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/2024

The report begins with a brief introduction and market overview of the Testosterone Replacement Therapy industry followed by its market scope and size. Next, the report provides an overview of market segmentation such as type, application, and region. The drivers, limitations, and opportunities for the market are also listed along with current trends and policies in the industry.

The key players profiled in this report include: AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Regions included:

o North America (United States, Canada, and Mexico)

o Europe (Germany, France, UK, Russia, and Italy)

o Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

o South America (Brazil, Argentina, Colombia)

o Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

The PDF Research only provides Table of Contents (ToC), scope of the report and research framework of the report.

Get a PDF Brochure of this Report: https://www.coherentmarketinsights.com/insight/request-pdf/2024

Key Benefits:

o This study gives a detailed analysis of drivers and factors limiting the market expansion of Testosterone Replacement Therapy

o The micro-level analysis is conducted based on its product types, end-user applications, and geographies

o Porters five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players

o By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Testosterone Replacement Therapy market

The research study can answer the following Key questions:

Table of Contents

Report Overview: It includes the Testosterone Replacement Therapy market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary: This section of the report gives information about Testosterone Replacement Therapy market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

Profiles of International Players: Here, key players of the Testosterone Replacement Therapy market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

Regional Study: All of the regions and countries analyzed in the Testosterone Replacement Therapy market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Get Offer on Report: https://www.coherentmarketinsights.com/insight/request-discount/2024

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, LATAM, West Europe, MENA Countries, Southeast Asia or Asia Pacific.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:Coherent Market Insights,1001 4th Ave,#3200 Seattle, WA 98154, U.S.Email: [emailprotected]Phone: US +1-206-701-6702/UK +44-020 8133 4027

Originally posted here:
Impact of COVID-19 on Testosterone Replacement Therapy Market 2020 Key Players, Opportunities, Challenges, Trend and Forecast by 2027 | Endo...


Page 668«..1020..667668669670..680690..»